The anti-inflammatory action of danazol and leuprorelin acetate depot on endometriosis is CRH independent

In: InflammoPharmacology · 2001 · vol. 9(3) , pp. 249–255 · doi:10.1163/156856001760209798 · W2032305206
article OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
AI-generated summary by claude@2026-06+body, 2026-06-08

This study found no difference in serum CRH levels between women with and without endometriosis, and danazol or leuprorelin treatments did not affect CRH during administration.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-08

This study measured circulating serum corticotropin-releasing hormone (CRH) in women with endometriosis and compared levels with controls, then assessed how 6-month treatment with danazol or leuprorelin acetate depot affected CRH concentrations. CRH levels were not significantly different between women with endometriosis and controls, and danazol or leuprorelin had no effect on CRH levels during the specific 6-month treatment period. However, CRH levels changed after treatment cessation: they were significantly lower 3 months after danazol and significantly higher after leuprorelin. This paper is centrally about endometriosis — it tests whether endometriosis and its anti-inflammatory hormonal treatments are associated with CRH changes and finds CRH independence during treatment.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (20)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK